Literature DB >> 14011436

Studies on delayed hypersensitivity in Hodgkin's disease.

A C AISENBERG.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE; NITROBENZENES; SKIN TESTS

Mesh:

Substances:

Year:  1962        PMID: 14011436      PMCID: PMC291126          DOI: 10.1172/JCI104654

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  20 in total

1.  Estimation of radiation effects at small exposures.

Authors:  H B JONES
Journal:  Fed Proc       Date:  1961-07

2.  The altered response to skin homografts and to delayed allergens in Hodgkin's disease.

Authors:  W D KELLY; R A GOOD; R L VARCO; M LEVITT
Journal:  Surg Forum       Date:  1958

3.  Immunologic studies in the lymphoblastomas. II. The ability to develop an eczematous sensitization to a simple chemical and the ability to accept passive transfer antibody.

Authors:  A ROSTENBERG; H C MCCRANEY; S M BLUEFARB
Journal:  J Invest Dermatol       Date:  1956-03       Impact factor: 8.551

4.  The effects of nitrogen mustard (methyl bis (beta-chloroethyl) amine HC1) on the immunological response of the rabbit. I. The effects of nitrogen mustard on the primary response to a bacterial antigen.

Authors:  D M GREEN
Journal:  Br J Exp Pathol       Date:  1958-04

5.  Further studies on the radiosensitive stages in hemolysin formation.

Authors:  W H TALIAFERRO; L O TALIAFERRO
Journal:  J Infect Dis       Date:  1954 Sep-Oct       Impact factor: 5.226

6.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

7.  Cutaneous anergy and Hodgkin's disease.

Authors:  W W SCHIER
Journal:  N Engl J Med       Date:  1954-03-04       Impact factor: 91.245

8.  Cutaneous reactions in the lymphoblastomas.

Authors:  A ROSTENBERG; S M BLUEFARB
Journal:  AMA Arch Derm Syphilol       Date:  1954-02

9.  Immunological function of the thymus.

Authors:  J F MILLER
Journal:  Lancet       Date:  1961-09-30       Impact factor: 79.321

10.  Circulating antibodies in reticuloses.

Authors:  M BARR; G H FAIRLEY
Journal:  Lancet       Date:  1961-06-17       Impact factor: 79.321

View more
  53 in total

1.  B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.

Authors:  K J Gajl-Peczalska; C D Bloomfield; H Sosin; J H Kersey
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.

Authors:  S V Payne; D B Jones; D G Haegert; J L Smith; D H Wright
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

3.  Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

4.  STUDIES OF LYMPHOCYTE TRANSFER REACTIONS IN HODGKIN'S DISEASE.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

5.  Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

Authors:  C Moroz; N Lahat; M Biniaminov; B Ramot
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers.

Authors:  P M Bolton; A M Mander; J M Davidson; S L James; R G Newcombe; L E Hughes
Journal:  Br Med J       Date:  1975-07-05

7.  Immune function of successfully treated lymphoma patients.

Authors:  G W King; B Yanes; P E Hurtubise; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  Persisting lymphocyte deficiences during remission in Hodgkin's disease.

Authors:  M Björkholm; G Holm; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

9.  Cell-mediated immunity in an ageing population.

Authors:  J P Girard; M Paychère; M Cuevas; B Fernandes
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

10.  Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; H Schaoua; R Moelle
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.